• Return to Headlines

Relatively Good Performance Detected in Shares of Biomarin Pharmac in the Biotechnology Industry (BMRN , VCYT , ADMS , RTRX , EXAS )

By Nick Russo

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming. This is what we found:

Biomarin Pharmac (NASDAQ:BMRN ) ranks first with a gain of 6.79%; Veracyte Inc (NASDAQ:VCYT ) ranks second with a gain of 4.96%; and Adamas Pharmaceu (NASDAQ:ADMS ) ranks third with a gain of 4.19%.

Retrophin Inc (NASDAQ:RTRX ) follows with a gain of 3.79% and Exact Sciences (NASDAQ:EXAS ) rounds out the top five with a gain of 3.66%.

SmarTrend recommended that its subscribers protect gains by selling shares of Biomarin Pharmac on April 17th, 2019 by issuing a Downtrend alert when the shares were trading at $85.22. Since that call, shares of Biomarin Pharmac have fallen 4.9%. We are now looking for when a new Uptrend will commence and will alert SmarTrend subscribers in real time.

Keywords: relative performance biomarin pharmac veracyte inc adamas pharmaceu retrophin inc exact sciences

Ticker(s): BMRN VCYT ADMS RTRX EXAS